Emily Shiffer June 17, 2022 In a surprising discovery that flies in the face of conventional medicine, McGill University researchers report that treating pain with anti-inflammatory medication, like ibuprofen or aspirin, may promote pain in the long term. The paper, published in Science Translational Medicine, suggests that inflammation, a normal part of injury recovery, helps resolve acute pain and...
Tag: <span>treatment</span>
Post
Pharmacy researchers develop nanoparticle-based treatment for glioblastoma
by University of Connecticut Design of PNAs and characterization of NPs. (A) Chemical structure of DNA, PNA, and serine-γ-PNA. (B) The sequence of oncomiR-21 and oncomiR-10b, where the underlined segment is the seed region. (C) PNAs used in the study. sγPNA-21 and sγPNA-10b are serine-γPNAs designed to bind the seed region of oncomiR-21 and oncomiR-10b, respectively....
Post
Promising treatment for Alzheimer’s disease
BAR-ILAN UNIVERSITY More than 55 million people worldwide were living with Alzheimer’s disease in 2020, according to Alzheimer’s Disease International. This figure is expected to almost double every 20 years, reaching 78 million in 2030 and 139 million in 2050. In 2021 the WHO Global Status Report estimated the annual worldwide cost of dementia as over...
Post
New breakthrough in the treatment of rheumatoid arthritis
ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY(UNIST) IMAGE: PROFESSOR SUNG HO PARK (CENTER) AND HIS RESEARCH TEAM IN THE DEPARTMENT OF BIOLOGICAL SCIENCES AT UNIST. CREDIT: UNIST A research team, led by Professor Sung Ho Park in the Department of Biological Sciences at UNIST announced the results of a study on osteoblasts that damage joint bones in patients...
Post
Improving treatment for hairy cell leukemia
by Melissa Rohman, Northwestern University Credit: Unsplash/CC0 Public Domain Patients with relapsed or refractory hairy cell leukemia who were treated with vemurafenib experienced excellent response and relapse-free survival, according to a recent clinical trial published in Blood. The results suggest that vemurafenib is an effective second-line treatment option for these patients. “This finding is important because...
Post
COPD: New, Simplified Treatment Guidelines
Neil Skolnik, MD January 06, 2023 I’m Dr Neil Skolnik. Today we are going to talk about the 2023 GOLD guide for COPD. The big news here is a more streamlined approach to treatment, combining what used to be categories C and D into one category — E — for exacerbations. There is continued emphasis on getting a...
Post
Dry Eye: Symptoms, Treatment, Prevention
BY AMY CAMPBELL, MS, RD, LDN, CDCES | DECEMBER 29, 2022 Diabetes is a condition that can affect the eyes. Some eye problems, such as diabetic retinopathy and macular edema, are well-known complications of diabetes. Dry eye is another eye condition that is common in people who have diabetes, although it’s not always discussed. The American Diabetes Association (ADA) shares...
Post
Study discovers novel therapeutic target to advance the treatment of diabetic eye diseases
by Agency for Science, Technology and Research (A*STAR), Singapore Graphical abstract. Credit: Theranostics (2022). DOI: 10.7150/thno.72947A recent study discovered a novel therapeutic target named ADAM10 that could be used to treat patients with Diabetic Retinopathy (DR), a condition that leads to blindness induced by prolonged diabetes. Abnormal blood vessel formation in the eyes of diabetic patients is...
Post
Which Hair Loss Treatment Is Right for Me?
Written by Alina Goldenberg, MD, MAS, FAAD | Reviewed by Mandy Armitage, MDPublished on March 24, 2022 Key takeaways: Hair loss is common in both men and women. Hair loss can be a sign of an underlying medical issue, so it’s important to see your primary care provider or a dermatologist for help. Treatments for hair loss...
Post
Updated rheumatoid arthritis treatment recommendations
by European Alliance of Associations for Rheumatology (EULAR) Flow chart. ACR, American College of Rheumatology; bDMARDs, biological disease-modifying antirheumatic drugs; csDMARDs, conventional synthetic DMARDs; FDA, Food and Drug Administration; JAK, Janus kinase; MTX, methotrexate; NMSC, non-melanoma skin caner; tsDMARDs, targeted synthetic DMARDs. Credit: Annals of the Rheumatic Diseases (2022). DOI: 10.1136/ard-2022-223356 Since their first publication...